Submitted by Anonymous (not verified) on 23 October 2025 - 9:30
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 6, Status: Authorised